Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Lisata Therapeutics aggregated by PharmaCompass.com.

    Client Virtual Booth

    LISATA THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Lisata Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    110 Allen Road, 2nd Floor Basking Ridge, NJ 07920
    Telephone
    Telephone
    +1 9088420100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.lisata.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lisatatx/
    Twitter
    Twitter
    https://twitter.com/lisata_tx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Lisata's Certepetide Shows Promise For Intrahepatic Cholangiocarcinoma
    Lisata's Certepetide Shows Promise For Intrahepatic Cholangiocarcinoma

    https://www.globenewswire.com/news-release/2024/07/10/2911056/18623/en/Lisata-Therapeutics-Certepetide-Shows-Promise-in-Improving-Standard-Treatment-for-Intrahepatic-Cholangiocarcinoma-in-a-Preclinical-Model.html

    GLOBENEWSWIRE
    10 Jul 2024
    Share Share
    Lisata Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial
    Lisata Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX Trial

    https://www.globenewswire.com/news-release/2024/06/13/2898249/18623/en/Lisata-Therapeutics-Announces-Full-Enrollment-of-Pancreatic-Cancer-Cohort-of-CENDIFOX-Trial.html

    GLOBENEWSWIRE
    13 Jun 2024
    Share Share
    Lisata Therapeutics: Participating In June 2024 Industry, Investor Events
    Lisata Therapeutics: Participating In June 2024 Industry, Investor Events

    https://www.globenewswire.com/news-release/2024/05/28/2889030/18623/en/Lisata-Therapeutics-to-Participate-in-Upcoming-June-2024-Industry-and-Investor-Events.html

    GLOBENEWSWIRE
    28 May 2024
    Share Share
    Lisata Receives EMA Paediatric Waiver For Certepetide In Pancreatic Cancer
    Lisata Receives EMA Paediatric Waiver For Certepetide In Pancreatic Cancer

    https://www.globenewswire.com/news-release/2024/05/20/2884845/18623/en/Lisata-Therapeutics-Receives-Paediatric-Investigation-Plan-Waiver-from-the-European-Medicines-Agency-for-Certepetide-in-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    20 May 2024
    Share Share
    Lisata Therapeutics Q1 2024 Financials And Business Update
    Lisata Therapeutics Q1 2024 Financials And Business Update

    https://www.globenewswire.com/news-release/2024/05/09/2879158/18623/en/Lisata-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    09 May 2024
    Share Share
    Lisata to Participate in Upcoming May 2024 Industry and Investor Events
    Lisata to Participate in Upcoming May 2024 Industry and Investor Events

    https://www.globenewswire.com/news-release/2024/05/08/2877781/18623/en/Lisata-Therapeutics-to-Participate-in-Upcoming-May-2024-Industry-and-Investor-Events.html

    GLOBENEWSWIRE
    08 May 2024
    Share Share
    Lisata Q1 2024 Results, Business Update On May 9
    Lisata Q1 2024 Results, Business Update On May 9

    https://www.globenewswire.com/news-release/2024/05/02/2874141/18623/en/Lisata-Therapeutics-to-Report-First-Quarter-2024-Financial-Results-and-Provide-a-Business-Update-on-Thursday-May-9-2024.html

    GLOBENEWSWIRE
    02 May 2024
    Share Share
    Lisata and Qilu Treat First Patient in LSTA1 Pancreatic Cancer Trial
    Lisata and Qilu Treat First Patient in LSTA1 Pancreatic Cancer Trial

    https://www.globenewswire.com/news-release/2024/04/23/2867557/18623/en/Lisata-Therapeutics-and-Qilu-Pharmaceutical-Announce-First-Patient-Treated-in-Qilu-s-Phase-2-Trial-in-China-of-LSTA1-in-Patients-with-Metastatic-Pancreatic-Ductal-Adenocarcinoma.html

    GLOBENEWSWIRE
    23 Apr 2024
    Share Share
    Lisata Therapeutics Announces FDA Orphan Drug Designation Granted to LSTA1
    Lisata Therapeutics Announces FDA Orphan Drug Designation Granted to LSTA1

    https://www.globenewswire.com/news-release/2024/04/09/2859986/18623/en/Lisata-Therapeutics-Announces-U-S-FDA-Orphan-Drug-Designation-Granted-to-LSTA1-for-the-Treatment-of-Osteosarcoma.html

    GLOBENEWSWIRE
    09 Apr 2024
    Share Share
    Lisata to Participate in Upcoming April 2024 Industry and Investor Events
    Lisata to Participate in Upcoming April 2024 Industry and Investor Events

    https://www.globenewswire.com/news-release/2024/04/03/2856927/18623/en/Lisata-Therapeutics-to-Participate-in-Upcoming-April-2024-Industry-and-Investor-Events.html

    GLOBENEWSWIRE
    03 Apr 2024
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    famar-2024-07-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search